IP Library Granted Patent US 8,288,544
Granted Patent B2
US 8,288,544 · App. 10/555,138 · Granted Oct 16, 2012

Electrochemical affinity biosensor system and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,288,544
App. No.
10/555,138
Granted
Oct 16, 2012
Kind
B2
Abstract

The present invention provides novel osmium-based electrochemical species for the detection of wide variety of analytes using immunological techniques. The present invention also provides diagnostic kits and test sensors supporting electrode structures that can be used with the osmium-based electrochemical species. The test sensor can be fabricated to support interdigitated arrays of electrodes that have been designed to provide amplification of the electrical signal amplification desired to analyze analytes that may be present at low concentrations.

Claims (36)

1. A compound of the formula:

wherein R and R 1 are the same or different and each can be selected from: 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, 5-5′-disubstituted-2,2′-bipyridyl, 1,10-phenanthrolinyl, 4,7-disubstituted-1,10-phenanthrolinyl, 5,6-disubstituted-1,10-phenanthrolinyl, or N,N′-dimethyl 2,2′-biimidazole, wherein each substituent is a methyl, ethyl, or phenyl group, and where the R and R 1 groups are coordinated to osmium through their nitrogen atoms; R 2 is hydrogen, methyl, or ethyl; B is a group comprising a ligand capable of binding to a specific analyte binding partner; Z is chloro or bromo; X is a counter ion; y is selected to provide a neutral salt; and m is 2 to 4.

2. The compound of claim 1 wherein R and R 1 are the same and are selected from 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, or 5-5′-disubstituted-2,2′-bipyridyl substituted with a methyl, an ethyl or a phenyl group.

3. The compound of claim 1 wherein X is selected from the group of: chloride, bromide, iodide, fluoride, tetrafluoroborate, perchlorate, nitrate, sulfate, carbonate, and sulfite.

4. The compound of claim 1 , wherein the compound is suitable for use in an electrochemical assay.

5. The compound of claim 1 wherein B comprises an epitope recognizable by an antibody capable of specific binding to an analyte.

6. The compound of claim 1 wherein B comprises an epitope capable of binding to an analyte selected from the group consisting of: a biowarfare agent, an abused substance, a therapeutic agent, an environmental pollutant, a protein or a hormone.

7. The compound of claim 1 comprising:

8. The compound of claim 7 wherein B comprises an epitope recognizable by an antibody capable of specific binding to an analyte.

9. The compound of claim 7 wherein B comprises an epitope capable of binding to an analyte selected from the group consisting of: a biowarfare agent, an abused substance, a therapeutic agent, an environmental pollutant, a protein or a hormone.

10. The compound of claim 7 , wherein the compound is suitable for use in an electrochemical assay.

11. A compound of the formula:

wherein R and R 1 are the same or different and each can be selected from: 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, 5-5′-disubstituted-2,2′-bipyridyl, 1,10-phenanthrolinyl, 4,7-disubstituted-1,10-phenanthrolinyl, 5,6-disubstituted-1,10-phenanthrolinyl, or N,N′-dimethyl 2,2′-biimidazole, wherein each substituent is a methyl, ethyl, or phenyl group, and where the R and R 1 groups are coordinated to osmium through their nitrogen atoms; R 2 is hydrogen, methyl, or ethyl; Z is chloro or bromo; X is a counter ion; and y is selected to provide a neutral salt; and m is 2 to 4.

12. The compound of claim 11 wherein R and R 1 are the same and are selected from 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, or 5-5′-disubstituted-2,2′-bipyridyl substituted with a methyl, an ethyl or a phenyl group.

13. The compound of claim 11 wherein X is selected from the group of: chloride, bromide, iodide, fluoride, tetrafluoroborate, perchlorate, nitrate, sulfate, carbonate, and sulfite.

14. The compound of claim 11 , wherein the compound is suitable for use in an electrochemical assay.

15. The compound of claim 11 comprising:

16. The compound of claim 15 , wherein the compound is suitable for use in an electrochemical assay.

17. A compound of the formula:

wherein R and R 1 are the same or different and each can be selected from: 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, 5-5′-disubstituted-2,2′-bipyridyl, 1,10-phenanthrolinyl, 4,7-disubstituted-1,10-phenanthrolinyl, 5,6-disubstituted-1,10-phenanthrolinyl, or N,N′-dimethyl 2,2′-biimidazole, wherein each substituent is a methyl, ethyl, or phenyl group, and where the R and R 1 groups are coordinated to osmium through their nitrogen atoms; R 2 is hydrogen, methyl, or ethyl; B is a group comprising a ligand capable of binding to a specific analyte binding partner; Z is chloro or bromo; X is a counter ion; and y is selected to provide a neutral salt; and m is 2 to 4.

18. The compound of claim 17 wherein R and R 1 are the same and are selected from 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, or 5-5′-disubstituted-2,2′-bipyridyl substituted with a methyl, an ethyl or a phenyl group.

19. The compound of claim 17 wherein X is selected from the group of: chloride, bromide, iodide, fluoride, tetrafluoroborate, perchlorate, nitrate, sulfate, carbonate, and sulfite.

20. The compound of claim 17 , wherein the compound is suitable for use in an electrochemical assay.

21. The compound of claim 17 wherein B comprises an epitope recognizable by an antibody capable of specific binding to an analyte.

22. The compound of claim 17 wherein B comprises an epitope capable of binding to an analyte selected from the group consisting of a biowarfare agent, an abused substance, a therapeutic agent, an environmental pollutant, a protein or a hormone.

23. The compound of claim 17 comprising:

24. The compound of claim 23 wherein B comprises an epitope recognizable by an antibody capable of specific binding to an analyte.

25. The compound of claim 23 wherein B comprises an epitope capable of binding to an analyte selected from the group consisting of: a biowarfare agent, an abused substance, a therapeutic agent, an environmental pollutant, a protein or a hormone.

26. The compound of claim 23 , wherein the compound is suitable for use in an electrochemical assay.

27. A compound of the formula:

wherein R and R 1 are the same or different and each can be selected from: 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, 5-5′-disubstituted-2,2′-bipyridyl, 1,10-phenanthrolinyl, 4,7-disubstituted-1,10-phenanthrolinyl, 5,6-disubstituted-1,10-phenanthrolinyl, or N,N′-dimethyl 2,2′-biimidazole, wherein each substituent is a methyl, ethyl, or phenyl group, and where the R and R 1 groups are coordinated to osmium through their nitrogen atoms; R 2 is hydrogen, methyl, or ethyl; Z is chloro or bromo; X is a counter ion; y is selected to provide a neutral salt; and m is 2 to 4.

28. The compound of claim 27 wherein R and R 1 are the same and are selected from 2,2′-bipyridyl, 4,4′-disubstituted-2,2′-bipyridyl, or 5-5′-disubstituted-2,2′-bipyridyl substituted with a methyl, an ethyl or a phenyl group.

29. The compound of claim 27 wherein X is selected from the group, of: chloride, bromide, iodide, fluoride, tetrafluoroborate, perchlorate, nitrate, sulfate, carbonate, and sulfite.

30. The compound of claim 27 , wherein the compound is suitable for use in an electrochemical assay.

31. The compound of claim 27 comprising:

32. The compound of claim 31 , wherein the compound is suitable for use in an electrochemical assay.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2006
From: DIEBOLD, ERIC R.; GHOSHAL, MITALI; DENG, DAVID Z.; TSAI, JANE S.C.
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 018309/0786 →